S&P 500   3,358.53 (+1.82%)
DOW   27,688.35 (+1.89%)
QQQ   276.13 (+1.68%)
AAPL   114.14 (+1.66%)
MSFT   209.36 (+0.74%)
FB   256.78 (+0.77%)
GOOGL   1,461.39 (+1.55%)
AMZN   3,159.81 (+2.09%)
TSLA   420.02 (+3.11%)
NVDA   518.65 (+0.72%)
BABA   276.05 (+1.83%)
CGC   14.31 (+0.99%)
GE   6.25 (+2.29%)
MU   49.13 (-0.02%)
AMD   78.82 (+0.97%)
T   28.51 (+1.68%)
F   6.75 (+3.69%)
ACB   4.85 (-3.96%)
GILD   62.85 (+0.96%)
NFLX   489.30 (+1.33%)
DIS   126.51 (+2.02%)
BAC   24.28 (+3.36%)
BA   166.10 (+6.45%)
S&P 500   3,358.53 (+1.82%)
DOW   27,688.35 (+1.89%)
QQQ   276.13 (+1.68%)
AAPL   114.14 (+1.66%)
MSFT   209.36 (+0.74%)
FB   256.78 (+0.77%)
GOOGL   1,461.39 (+1.55%)
AMZN   3,159.81 (+2.09%)
TSLA   420.02 (+3.11%)
NVDA   518.65 (+0.72%)
BABA   276.05 (+1.83%)
CGC   14.31 (+0.99%)
GE   6.25 (+2.29%)
MU   49.13 (-0.02%)
AMD   78.82 (+0.97%)
T   28.51 (+1.68%)
F   6.75 (+3.69%)
ACB   4.85 (-3.96%)
GILD   62.85 (+0.96%)
NFLX   489.30 (+1.33%)
DIS   126.51 (+2.02%)
BAC   24.28 (+3.36%)
BA   166.10 (+6.45%)
S&P 500   3,358.53 (+1.82%)
DOW   27,688.35 (+1.89%)
QQQ   276.13 (+1.68%)
AAPL   114.14 (+1.66%)
MSFT   209.36 (+0.74%)
FB   256.78 (+0.77%)
GOOGL   1,461.39 (+1.55%)
AMZN   3,159.81 (+2.09%)
TSLA   420.02 (+3.11%)
NVDA   518.65 (+0.72%)
BABA   276.05 (+1.83%)
CGC   14.31 (+0.99%)
GE   6.25 (+2.29%)
MU   49.13 (-0.02%)
AMD   78.82 (+0.97%)
T   28.51 (+1.68%)
F   6.75 (+3.69%)
ACB   4.85 (-3.96%)
GILD   62.85 (+0.96%)
NFLX   489.30 (+1.33%)
DIS   126.51 (+2.02%)
BAC   24.28 (+3.36%)
BA   166.10 (+6.45%)
S&P 500   3,358.53 (+1.82%)
DOW   27,688.35 (+1.89%)
QQQ   276.13 (+1.68%)
AAPL   114.14 (+1.66%)
MSFT   209.36 (+0.74%)
FB   256.78 (+0.77%)
GOOGL   1,461.39 (+1.55%)
AMZN   3,159.81 (+2.09%)
TSLA   420.02 (+3.11%)
NVDA   518.65 (+0.72%)
BABA   276.05 (+1.83%)
CGC   14.31 (+0.99%)
GE   6.25 (+2.29%)
MU   49.13 (-0.02%)
AMD   78.82 (+0.97%)
T   28.51 (+1.68%)
F   6.75 (+3.69%)
ACB   4.85 (-3.96%)
GILD   62.85 (+0.96%)
NFLX   489.30 (+1.33%)
DIS   126.51 (+2.02%)
BAC   24.28 (+3.36%)
BA   166.10 (+6.45%)
Log in
NASDAQ:VSAR

Versartis Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$1.19
0.00 (0.00 %)
(As of 10/15/2018)
Add
Compare
Today's Range
$1.18
Now: $1.19
$1.30
50-Day Range
$1.19
MA: $1.19
$1.19
52-Week Range
$1.14
Now: $1.19
$2.76
Volume349,963 shs
Average Volume479,436 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Versartis, Inc. operates as an endocrine-focused biopharmaceutical company in the United States. It is developing somavaratan, a long-acting recombinant human growth hormone for the treatment of growth hormone deficiency. The company was founded in 2008 and is headquartered in Menlo Park, California.
Read More
Versartis logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.72 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VSAR
CUSIPN/A
Phone650-963-8580

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive VSAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VSAR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Versartis (NASDAQ:VSAR) Frequently Asked Questions

How were Versartis' earnings last quarter?

Versartis Inc (NASDAQ:VSAR) posted its earnings results on Tuesday, August, 7th. The biopharmaceutical company reported ($0.27) EPS for the quarter, topping the consensus estimate of ($0.96) by $0.69.
View Versartis' earnings history
.

Who are some of Versartis' key competitors?

What other stocks do shareholders of Versartis own?

Who are Versartis' key executives?

Versartis' management team includes the following people:
  • Mr. Jay P. Shepard, Pres, CEO & Director (Age 60)
  • Ms. Tracy M. Woody, Chief Commercial Officer (Age 48)
  • Dr. Jeffrey L. Cleland, Co-Founder (Age 53)
  • Dr. Joshua Silverman Ph.D., Co-Founder
  • Mr. Kevin Haas, VP of Fin. (Age 53)

What is Versartis' stock symbol?

Versartis trades on the NASDAQ under the ticker symbol "VSAR."

What is Versartis' stock price today?

One share of VSAR stock can currently be purchased for approximately $1.19.

What is Versartis' official website?

The official website for Versartis is www.versartis.com.

How can I contact Versartis?

Versartis' mailing address is 1020 Marsh Rd, Menlo Park CA, 94025. The biopharmaceutical company can be reached via phone at 650-963-8580 or via email at [email protected]

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.